Lonza Drug Product Services Participates in the RealHOPE Project to Assess and Improve Protein Stability Read more
FDA Accepts for Review Libtayo (cemiplimab-rwlc) in Combination with Chemotherapy for First-line Treatment of Advanced NSCLC Read more
Merck and Ridgeback Announce Supply Agreement with UNICEF for Molnupiravir, an Investigational Oral Antiviral COVID-19 Medicine Read more
Boehringer Ingelheim announces collaboration with MabGenesis to discover and develop novel monoclonal antibodies in canine Read more
BlueRock Therapeutics Announces First Patient Dosed in Canada in Phase 1 Trial in Patients with Advanced Parkinson’s Disease Read more
Green Valley Obtains IND Approval from U.S. FDA for Sodium Oligomannate’s Global Phase II Clinical Trial in Treating Parkinson’s Disease Read more